OBJECTIVE: This is a review of the effects of Chinese herbal medicine (CHM) used alone to treat lumbar disc herniation (LDH).
INTRODUCTION
Displacement of the lumbar disc beyond a damaged annulus fibrosus is defined as lumbar disc herniation (LDH). 1 Its prevalence is about 1%-3% in European countries. The highest incidence is among people aged 30-50 years and the ratio of male to female is 2∶1. 2 The commonest symptoms caused by LDH are lower back pain (LBP) and sciatica (a specific subgroup of LBP). 3 It imposes an economic burden on patients because of their frequent absences from work. 4 Some conventional treatments for LBP, including various surgical treatments, non-steroidal anti-inflammatory drugs (NSAIDs), neurotrophics, and dehydrating drugs, have positive effects. However, some adverse effects of Western Medical treatments are unavoidable. The risk of gastrointestinal bleeding with NSAIDs is high in elderly patients. 5 In the practice of Traditional Chinese Medicine (TCM), Chinese herbal medicine (CHM) has long been used to treat LDH. In terms of TCM theory, LDH is known as "Yao Bi" and is usually caused by blood stasis and Qi stagnation, cold-dampness, or deficiencies in liver and kidney function. Recently, the effectiveness of CHM for treating LDH has been reported widely. However, many of these studies did not evaluate the effects of CHM used alone. The present systematic review aimed to use evidence from published randomized clinical trials to evaluate the efficacy of CHM used alone to treat LDH.
METHODS

Search strategy
Domestic databases, including the Chinese Biomedical databases, Chinese National Knowledge Infrastructure, Wanfang database, and China Science and Technology Journal database (CSTJ), were searched. The overseas databases searched included the Cochrane Library, Web of Science, MEDLINE, and EMBASE. All databases were searched from inception up to February 2013. Papers presented at the International Congress of the Chinese Orthopedic Association from its inception up to 2012 were also manually searched. Unpublished studies were identified using Google. The terms used for searching were as follows: (a) low back pain. 
Inclusion criteria
Types of study: all randomized controlled trials related to LDH were included, regardless of language. Types of participant: adult patients with a definite diagnosis of LDH. Patients with other diseases, such as trauma, tumor, fracture, infection, muscle strain, or spinal deformity, were excluded. Types of intervention: the treatment groups included only used CHM/formulae either internally or externally or both. The control groups used other treatments such as placebos and Western Medicine-type medications. Studies in which CHM was used in the control groups were excluded, as were those that used non-Chinese herbal medicines. Types of outcome measure: outcome measures were clinical efficacy, adverse effects, Japanese Orthopedic Association (JOA) scores, and Visual Analogue Scale (VAS) scores.
Data extraction and assessment
All articles were identified by the specific search strategies described above. Two reviewers (Luo and Huang) assessed the articles independently. Any disagreements were resolved by a third reviewer (Hu). Similarly, the data were independently extracted by two researchers (Luo and Huang) according to the defined criteria and differences of opinion resolved by the third reviewer (Hu). Figure 1 is a flow chart depicting the selection process and the reasons for exclusion. The risk of bias was evaluated using the Cochrane Collaboration's risk of bias criteria, which are as follows: (a) random sequence generation; (b) allocation concealment; (c) blinding of participants and personnel; (d) blinding of outcome assessment; (e) incomplete outcome data; (f ) selective reporting; and (g) other biases. 6 Two of the authors (Luo and Huang) independently evaluated the quality of the studies and consulted with the other authors when their viewpoints differed.
Data analysis
The program Revman 5.1 (Cochrane Collaboration, Oxford, UK) was used to compare the outcomes of the treatment groups with the control groups for all statistical analyses. Odds ratio (OR) were used to compare dichotomous data and mean differences (MD) to compare continuous variables and 95% confidence intervals (CI) calculated for them. Meta-analyses were performed where the interventions were comparable and the heterogeneity low. Heterogeneity was assessed based on the χ 2 test. A random effects model was used for meta-analysis where there was significant heterogeneity (P<0.10) and a fixed effects model where there was not significant heterogeneity (P≥0.10).
RESULTS
Study selection and characteristics
In total, 2415 studies were retrieved using the search terms. Of these studies, 1351 were in English and 1064 in Chinese. One hundred and four studies were excluded because of duplication and a further 2238 after reading their titles and abstracts. An additional 453 studies were excluded because they were not relevant to LDH, 726 studies because they were not relevant to CHM, 188 studies because they were not clinical trials, 845 studies because multiple inventions had been performed in both control and treatment groups, and 26 studies because they were reviews. The full texts of the remaining 73 studies were obtained for further evaluation, after which 65 of them were excluded based on our evaluation of the detailed data: 36 because CHMs were used in the control group, 17 because there were multiple inventions in the treatment groups (not noted in the abstracts), and 12 because they were not randomized controlled trials ( Figure 1 ). Finally, eight studies remained, all of which had been published in Chinese journals and performed in China. [7] [8] [9] [10] [11] [12] [13] [14] These eight trials involved 1146 patients in total (Table 1) .
Study quality
Only two of the studies 7 
Author
Li BJ 2009 7 Ye KX 2006 8 Diao JH 2008 9 Li CJ 2009 10 Chen FH 2011 11 Ma YX 2011 12 Zhao CW 2010 13 Wang LX 2012 14 (Figures 2 and 3) .
Assessment of outcomes
The rate of cure was used as an indicator of clinical efficacy in all of the assessed studies. [7] [8] [9] [10] [11] [12] [13] [14] One study 8 used the Manipulations of Diagnostic and Therapeutic Effect of Chinese Medicine, six used the Criteria of Diagnostic and Therapeutic Effect of Chinese Medicine for Disease, and the remaining one 14 used criteria devised by the author. Based on these criteria, outcomes were allocated to one of four levels: cure, significantly effective, effective, and ineffective. Rate of cure was to be calculated from the number of cured cases (first level); however, this meta-analysis was abandoned because the assessed studies were too clinically diverse, with variable types of intervention and different treatment courses.
Curative rate
Five studies 7, 9, 10, 12, 14 compared CHM with Western Medicine, two compared CHM with physiotherapy, and one compared CHM with placebo. In seven studies, 7, [9] [10] [11] [12] [13] [14] the CHM groups had a higher rate of cure than the control groups. One study reported no difference between CHM and physiotherapy (Figure 4 ).
JOA scores
In the one study 11 that used JOA scores, these scores were higher in the CHM group than in the control group [MD=7.78, 95% CI (6.67, 8.89)].
VAS scores
In the one study 14 that used VAS scores, these scores were lower in the CHM group than in the control group [MD=-0.72, 95% CI (-0.86,-0.58)].
Adverse effects
Three studies 7, 12, 14 reported adverse effects, specifically stomach discomfort. All three studies reported no differences between the CHM and control groups in adverse effects ( Figure 5 ).
Publication bias
Funnel plots produced to assess publication bias showed an asymmetrical distribution ( Figure 6 ). Thus, there is a publication bias in our review.
DISCUSSION
Our review shows that CHM therapy alone produces a better clinical outcome than other therapies in patients with LDH. There was no difference between CHM and Western Medicine in terms of the risk of adverse effects. However, methodological limitations compromise the reliability of these conclusions. 
Reasons for the possible effectiveness of CHM
Experimental studies have shown that CHMs may help to prevent degeneration of the lumbar disc and that they have analgesic effects. The mechanisms that underlie the effects of CHM in LDH remain unknown; however, CHM are known to have significant anti-inflammatory effects. In animal models, Yaotuitong capsules 15 reportedly significantly reduce prostaglandin E2 and 5-hydroxytryptamine concentrations in injured nerve roots. CHM 16 can increase type II collagen concentrations and decrease expression of metalloproteinase 3, metalloproteinase 13, and interleukin-1β in degenerated discs. These studies may explain why CHM both relieves the symptoms of LDH and also prevents disc degeneration. clear about blinding of participants and personnel and blinding of outcome assessments. Thus, the likelihoods of performance biases and detection biases were high. (d) None of the studies mentioned attrition or withdrawal rates. Intention-to-treat analyses were not performed in any of the studies assessed. Thus, it is possible that there was a high risk of attrition bias. Overall, our findings therefore provide limited evidence on this topic.
How does this review differ from other reviews?
Several systematic reviews of CHM have reported similar findings on this topic. A systematic review 17 of a Duhuojishen decoction included various studies; however, in these studies, the treatment groups received CHM combined with other therapies. With the aim of evaluating the efficacy of CHM alone in the treatment of LDH, we only included studies in which the treatment group received CHM alone. Although their methodological quality was low, the studies we identified did provide some information that is relevant to clinical practice. Studies of LBP treatment with herbal medicines performed outside China have been included in previous systematic reviews. 18, 19 However, the herbal medicines used in those studies are not the same as those used in CHM and those studies were only included to guide basic research and clinical treatments. We excluded clinical studies of herbal medicines that were not guided by TCM theory.
Recommendations for future clinical research and practice
Future studies should describe their randomization procedures in greater detail, perform allocation concealment as far as possible, apply a blinding method during the assessment procedure, and report intention-to-treat analyses. There is a need for large clinical trials to test the efficacy of CHM. We recommend that CHM should be combined with other LDH therapies, such as Western Medicine and physiotherapy.
